RANCONA® TRIO Receives Canadian Registration For Pulses

Jan 13, 2021

UPL AgroSolutions Canada Inc. is pleased to receive registration from the Canadian Pest Management Regulatory Agency for the use of RANCONA® TRIO Seed Treatment on pulses. Trusted in cereals since 2017, RANCONA TRIO offers improved crop emergence, increased stands and healthier, more vigorous plants to growers of pulse crops.

“UPL is committed to expanding our product offerings for pulse growers in Canada, and the recent approval of RANCONA TRIO is taking another step to further that commitment,” says Tony Dalgliesh, Canada Marketing Portfolio Manager – Seed Treatment, UPL AgroSolutions Canada. “RANCONA TRIO will provide growers with a powerful tool to help combat tough seed and seedling diseases in their pulse crops.”

HIGH-PERFORMANCE PROTECTION

With advanced-generation seed treatment technology, RANCONA TRIO ensures that growers are maximizing their seed treatment investment and yield potential. Three powerful fungicides offer multi-mode combination with both contact and systemic activity for maximum protection against a broadspectrum of seed and seedling diseases in pulses and cereals.

SUPERIOR FORMULATION TECHNOLOGY

RANCONA TRIO’s easy-to-use (ETU) formulation means no dilution required, less sticking and clumping, low dust levels, easy cleanup and a lower freezing point. The flowable application technology provides superior coverage and adhesion, so more active ingredient ends up on the seed and not on the equipment, delivering more consistent protection under a wider range of conditions.

To learn more about RANCONA TRIO or any of our leading product solutions, contact your local UPL AgroSolutions Canada representative or visit ranconatrio.ca.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.